scispace - formally typeset
M

Marco Salvetti

Researcher at Sapienza University of Rome

Publications -  294
Citations -  13327

Marco Salvetti is an academic researcher from Sapienza University of Rome. The author has contributed to research in topics: Multiple sclerosis & Medicine. The author has an hindex of 44, co-authored 263 publications receiving 10931 citations. Previous affiliations of Marco Salvetti include Max Planck Society & Istituto Neurologico Mediterraneo.

Papers
More filters
Journal ArticleDOI

B cells and multiple sclerosis.

TL;DR: Findings indicate that substantial numbers of B cells that are infected with Epstein-Barr virus accumulate in these intrameningeal follicles and in white matter lesions and are probably the target of a cytotoxic immune response in MS.
Journal ArticleDOI

Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study

Jens Kuhle, +98 more
TL;DR: MRI lesion load, OCB and age at CIS are validated as the strongest independent predictors of conversion to CDMS in this multicentre setting.
Journal ArticleDOI

CD161highCD8+T cells bear pathogenetic potential in multiple sclerosis

TL;DR: Variations of CD161 expression on CD8(+) T cells identify a subset of lymphocytes with proinflammatory characteristics that have not been previously reported in multiple sclerosis and are likely to contribute to disease immunopathology.
Journal ArticleDOI

Non-myeloablative autologous haematopoietic stem cell transplantation expands regulatory cells and depletes IL-17 producing mucosal-associated invariant T cells in multiple sclerosis

TL;DR: It is proposed that a favourably modified balance of regulatory and pro-inflammatory lymphocytes underlies the suppression of central nervous system inflammation in patients with multiple sclerosis following non-myeloablative autologous haematopoietic stem cell transplantation with a conditioning regimen consisting of cyclophosphamide and alemtuzumab.